Franz B. Humer, Director at Allogene Therapeutics, Inc. (ALLO), sold 11,200 shares at $2.34 ($26K) on 2024-05-30, disclosed to the SEC on 2024-06-03.
Seasonal sale ($26k) by Director — this insider has traded ALLO in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |